Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Rapid Microbiology Screening in Pharmaceutical Workflows.

Surrette C, Scherer B, Corwin A, Grossmann G, Kaushik AM, Hsieh K, Zhang P, Liao JC, Wong PK, Wang TH, Puleo CM.

SLAS Technol. 2018 Aug;23(4):387-394. doi: 10.1177/2472630318779758.

PMID:
30027813
2.

Dual detection for non-aqueous capillary electrophoresis combining contactless conductivity detection and mass spectrometry.

Beutner A, Scherer B, Matysik FM.

Talanta. 2018 Jun 1;183:33-38. doi: 10.1016/j.talanta.2018.02.012. Epub 2018 Feb 6.

PMID:
29567184
3.

Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody.

Favuzza P, Guffart E, Tamborrini M, Scherer B, Dreyer AM, Rufer AC, Erny J, Hoernschemeyer J, Thoma R, Schmid G, Gsell B, Lamelas A, Benz J, Joseph C, Matile H, Pluschke G, Rudolph MG.

Elife. 2017 Feb 14;6. pii: e20383. doi: 10.7554/eLife.20383.

4.

Vasoactive-ventilation-renal score reliably predicts hospital length of stay after surgery for congenital heart disease.

Scherer B, Moser EA, Brown JW, Rodefeld MD, Turrentine MW, Mastropietro CW.

J Thorac Cardiovasc Surg. 2016 Nov;152(5):1423-1429.e1. doi: 10.1016/j.jtcvs.2016.07.070. Epub 2016 Aug 20.

5.

Dietary butyrylated high-amylose starch reduces azoxymethane-induced colonic O(6)-methylguanine adducts in rats as measured by immunohistochemistry and high-pressure liquid chromatography.

Le Leu RK, Scherer BL, Mano MT, Winter JM, Lannagan T, Head RJ, Lockett T, Clarke JM.

Nutr Res. 2016 Sep;36(9):982-988. doi: 10.1016/j.nutres.2016.06.006. Epub 2016 Jun 7.

PMID:
27632918
6.

Butyrylated starch affects colorectal cancer markers beneficially and dose-dependently in genotoxin-treated rats.

Toden S, Lockett TJ, Topping DL, Scherer BL, Watson EJ, Southwood JG, Clarke JM.

Cancer Biol Ther. 2014;15(11):1515-23. doi: 10.4161/15384047.2014.955764.

7.

Divergent functions of orthologous NAC transcription factors in wheat and rice.

Distelfeld A, Pearce SP, Avni R, Scherer B, Uauy C, Piston F, Slade A, Zhao R, Dubcovsky J.

Plant Mol Biol. 2012 Mar;78(4-5):515-24. doi: 10.1007/s11103-012-9881-6. Epub 2012 Jan 26.

8.

Evaluation of the brain and kidney renin-angiotensin system and oxidative stress in neonatal handled rats.

Rodriguez DL, de Mesquita FC, Attolini D, de Borba BS, Scherer PS, Almeida PH, da Costa VL, Scherer BS, Schmitt VM, de Oliveira JR, Donadio MV.

Dev Psychobiol. 2012 Nov;54(7):706-13. doi: 10.1002/dev.20620. Epub 2011 Nov 29.

PMID:
22127847
9.

Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated rats.

Clarke JM, Young GP, Topping DL, Bird AR, Cobiac L, Scherer BL, Winkler JG, Lockett TJ.

Carcinogenesis. 2012 Jan;33(1):197-202. doi: 10.1093/carcin/bgr254. Epub 2011 Nov 10.

10.

Utilization of modified NFL combine testing to identify functional deficits in athletes following ACL reconstruction.

Myer GD, Schmitt LC, Brent JL, Ford KR, Barber Foss KD, Scherer BJ, Heidt RS Jr, Divine JG, Hewett TE.

J Orthop Sports Phys Ther. 2011 Jun;41(6):377-87. doi: 10.2519/jospt.2011.3547. Epub 2011 Feb 2.

11.

Transverse femoral implant prominence: four cases demonstrating a preventable complication for ACL reconstruction.

Argintar E, Scherer B, Jordan T, Klimkiewicz J.

Orthopedics. 2010 Dec 1;33(12):923. doi: 10.3928/01477447-20101021-29.

PMID:
21162497
12.

Can indole-based extracts prevent colorectal cancer via early apoptotic pathways?

Toden S, Scherer BL, Clarke JM.

Cancer Biol Ther. 2010 Mar 1;9(5):380-2. Epub 2010 Mar 1. Review. No abstract available.

PMID:
20168074
13.

Selenised casein protects against AOM-induced colon tumors in Sprague Dawley rats.

McIntosh GH, Royle PJ, Lesno S, Scherer BL.

Nutr Cancer. 2006;54(2):209-15.

PMID:
16898865
14.

Large-scale, high-throughput validation of short hairpin RNA sequences for RNA interference.

Lamarcq LH, Scherer BJ, Phelan ML, Kalnine NN, Nguyen YH, Kabakova T, Chen X, Tan M, Chang C, Berlon C, Campos-Gonzalez R, Gao GJ, Golz S, Vysotski ES, Farmer AA.

J Biomol Screen. 2006 Apr;11(3):236-46. Epub 2006 Feb 20.

PMID:
16490771
15.
16.

Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation.

Ju XS, Hacker C, Scherer B, Redecke V, Berger T, Schuler G, Wagner H, Lipford GB, Zenke M.

Gene. 2004 Apr 28;331:159-64.

PMID:
15094202
17.

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA.

Nature. 2003 Sep 11;425(6954):191-6. Epub 2003 Aug 24.

PMID:
12939617
18.

Application of hydrophobic anion-exchange phases in capillary electrochromatography.

Scherer B, Steiner F.

J Chromatogr A. 2001 Jul 27;924(1-2):197-209.

PMID:
11521866
19.

Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells.

Bauer M, Redecke V, Ellwart JW, Scherer B, Kremer JP, Wagner H, Lipford GB.

J Immunol. 2001 Apr 15;166(8):5000-7.

20.

Risk of prostate carcinoma death in patients with lymph node metastasis.

Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG.

Cancer. 2001 Jan 1;91(1):66-73.

PMID:
11148561
21.
22.

Instrumentation for capillary electrochromatography.

Steiner F, Scherer B.

J Chromatogr A. 2000 Jul 28;887(1-2):55-83. Review.

PMID:
10961304
23.

Predicting the survival of bladder carcinoma patients treated with radical cystectomy.

Cheng L, Weaver AL, Leibovich BC, Ramnani DM, Neumann RM, Scherer BG, Nehra A, Zincke H, Bostwick DG.

Cancer. 2000 May 15;88(10):2326-32.

PMID:
10820355
24.

Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.

Cheng L, Neumann RM, Weaver AL, Cheville JC, Leibovich BC, Ramnani DM, Scherer BG, Nehra A, Zincke H, Bostwick DG.

Am J Clin Pathol. 2000 Feb;113(2):275-9.

PMID:
10664630
25.

Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression.

Cheng L, Pisansky TM, Sebo TJ, Leibovich BC, Ramnani DM, Weaver AL, Scherer BG, Blute ML, Zincke H, Bostwick DG.

Clin Cancer Res. 1999 Oct;5(10):2820-3.

26.

Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal.

Cheng L, Weaver AL, Neumann RM, Scherer BG, Bostwick DG.

Cancer. 1999 Sep 15;86(6):1035-43.

PMID:
10491531
27.

Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion.

Cheng L, Neumann RM, Scherer BG, Weaver AL, Leibovich BC, Nehra A, Zincke H, Bostwick DG.

Cancer. 1999 Jun 15;85(12):2638-47.

PMID:
10375113
28.

p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression?

Cheng L, Leibovich BC, Bergstralh EJ, Scherer BG, Pacelli A, Ramnani DM, Zincke H, Bostwick DG.

Cancer. 1999 Jun 1;85(11):2455-9.

PMID:
10357418
29.

Predictors of cancer progression in T1a prostate adenocarcinoma.

Cheng L, Bergstralh EJ, Scherer BG, Neumann RM, Blute ML, Zincke H, Bostwick DG.

Cancer. 1999 Mar 15;85(6):1300-4.

PMID:
10189135
30.

Translation initiation factor eIF-2. Cloning and expression of the human cDNA encoding the gamma-subunit.

Gaspar NJ, Kinzy TG, Scherer BJ, Hümbelin M, Hershey JW, Merrick WC.

J Biol Chem. 1994 Feb 4;269(5):3415-22.

31.

Expression of a phosphorylation-resistant eukaryotic initiation factor 2 alpha-subunit mitigates heat shock inhibition of protein synthesis.

Murtha-Riel P, Davies MV, Scherer BJ, Choi SY, Hershey JW, Kaufman RJ.

J Biol Chem. 1993 Jun 15;268(17):12946-51.

32.

[Grading of clinical findings and stage classification in arterial hypertension].

Scherer B, Lorenz R.

Internist (Berl). 1992 Aug;33(8):532-5. Review. German. No abstract available.

PMID:
1526717
33.

[Kidney failure as a consequence of sarcoidosis].

Schindlbeck NE, Lechner M, Scherer B.

Dtsch Med Wochenschr. 1992 Mar 27;117(13):494-8. German.

PMID:
1551374
34.

Cryopreservation evaluated with mitochondrial and Z line ultrastructure in striated muscle.

Dalen H, Scheie P, Nassar R, High T, Scherer B, Taylor I, Wallace NR, Sommer JR.

J Microsc. 1992 Feb;165(Pt 2):239-54.

PMID:
1564722
35.

Stimulation of protein synthesis in COS cells transfected with variants of the alpha-subunit of initiation factor eIF-2.

Choi SY, Scherer BJ, Schnier J, Davies MV, Kaufman RJ, Hershey JW.

J Biol Chem. 1992 Jan 5;267(1):286-93.

36.

[Diagnosis of acute myositis. Magnetic resonance tomography with Gd-DTPA].

Schedel H, Vogl T, Reimers CD, Ziegler L, Scherer B, Hahn D, Habekost M.

Rofo. 1991 Oct;155(4):370-2. German. No abstract available.

PMID:
1932732
37.

Does hormone analysis predict the antihypertensive response of basic medical treatment?

Witzgall H, Scherer B, Lange HH, Weber PC.

Herz. 1989 Jun;14(3):197-203.

PMID:
2661389
38.

[Kidney diseases and increased occurrence of atherosclerosis].

Scherer B.

Internist (Berl). 1989 May;30(5):304-8. Review. German. No abstract available.

PMID:
2661473
39.

[Kidney diseases and hypertension].

Scherer B.

Urologe A. 1988 Nov;27(6):307-12. Review. German.

PMID:
3070895
40.

[The main features of an electronic data processing polyclinic information system in East Germany].

Bohndorf HJ, Friedrich G, Scherer B, Schneider HJ, Ressel E, Wolf B.

Z Gesamte Hyg. 1988 Oct;34(10):556-8. German. No abstract available.

PMID:
3201794
41.

[Superfluous diagnosis in nephrology and hypertonology].

Held E, Scherer B.

Internist (Berl). 1986 Sep;27(9):544-51. German. No abstract available.

PMID:
3531071
42.

Geometry of cell and bundle appositions in cardiac muscle: light microscopy.

Sommer JR, Scherer B.

Am J Physiol. 1985 Jun;248(6 Pt 2):H792-803.

PMID:
4003560
43.

Prostaglandin excretion after furosemide in normal and low-renin essential hypertension.

Scherer B, Witzgall H, Weber PC.

Klin Wochenschr. 1984 Aug 16;62(16):777-82.

PMID:
6384651
44.

Prostaglandins and hypertension.

Weber PC, Scherer B, Siess W.

Adv Exp Med Biol. 1984;164:269-81. No abstract available.

PMID:
6695576
45.

[PAR-DOK--a contribution to rationalization in roentgen diagnosis. 2: Organizational variants of the project].

Bohndorf HJ, Dietze R, Lauterbach D, Scherer B, Schneider HJ.

Radiol Diagn (Berl). 1984;25(1):93-101. German. No abstract available.

PMID:
6608116
46.

[PAR-DOK--a contribution to rationalization in roentgen diagnosis. 1: Description of findings].

Bohndorf HJ, Dietze R, Lauterbach D, Scherer B, Schneider HJ.

Radiol Diagn (Berl). 1984;25(1):85-91. German. No abstract available.

PMID:
6608115
47.

[Medical care records--a tool in the ambulatory and hospital care process].

Bohndorf HJ, Scherer B, Schneider HJ.

Z Arztl Fortbild (Jena). 1984;78(11):427-33. German. No abstract available.

PMID:
6475117
49.

Studies on the mechanism by which ACTH stimulates renin activity and angiotensin II formation in man.

Oelkers W, Köhler A, Belkien L, Fuchs-Hammoser R, Maiga M, Scherer B, Weber PC.

Acta Endocrinol (Copenh). 1982 Aug;100(4):573-80.

PMID:
6289585
50.

Acute haemodynamic and hormonal effects of captopril are diminished by indomethacin.

Witzgall H, Hirsch F, Scherer B, Weber PC.

Clin Sci (Lond). 1982 Jun;62(6):611-5.

PMID:
7044652

Supplemental Content

Loading ...
Support Center